NLSP

NLS Pharmaceutics AG NLSP

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NLSP OCEA BACK PRE SRZN CERO SABS BCTXW NUWE CELU
6M -87.93 % -85.71 % 160.00 % 103.68 % 138.24 % -99.18 % 115.64 % -20.57 % -80.66 % -25.85 %
YTD -86.65 % -99.83 % -89.76 % 221.30 % 67.02 % -99.93 % 4.04 % -81.70 % -95.69 % -40.68 %
1Y -85.30 % -99.84 % -89.34 % 223.01 % 94.60 % -99.91 % -9.81 % -83.05 % -95.13 % -42.76 %
3Y -99.42 % -99.99 % -97.93 % -42.61 % 248.64 % -100.00 % -44.03 % -97.22 % -99.98 % -88.85 %
5Y -99.75 % -99.99 % -99.61 % -83.98 % -84.31 % -100.00 % -96.20 % -93.00 % -100.00 % -98.85 %
10Y -99.75 % -99.99 % -99.88 % -83.98 % -84.31 % -100.00 % -96.20 % -93.00 % -100.00 % -98.67 %
From the beginning -99.75 % -99.99 % -99.88 % -83.98 % -84.31 % -100.00 % -96.20 % -93.00 % -100.00 % -98.67 %

Dividend

Prenetics Global Limited